COMP <GO>
XBI vs XLB // OPERATING MARGIN
SPDR S&P Biotech ETF (NYSE) VS. Materials Select Sector SPDR Fund (NYSE) • 15-METRIC TALLY: XBI 1
— XLB 1
■ METRIC PARITY
LAST: $155.98 (+0.18%) • MKT CAP: $7.40B
operating-margins
—
LAST: $52.74 (+1.28%) • MKT CAP: $6.00B
operating-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XBI VS. XLB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XBI | XLB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.30% | 1.30% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 70.9 | -16.80 | XLB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.40B | $6.00B | $1.40B | XBI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XBI REV | XLB REV | XBI GROSS % | XLB GROSS % | XBI FCF | XLB FCF |
|---|---|---|---|---|---|---|
| INSPECT INDIVIDUAL XBRL MODELS AT XBI FA <GO> AND XLB FA <GO>. | ||||||
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XBI // BETA —
XLB // BETA —